Clinical Trial Update: Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma [Phase 2]

View source ↗

Summary

A Phase 2 trial of nelfinavir mesylate for Kaposi sarcoma has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kaposi Sarcoma

Drugs mentioned

• Nelfinavir mesylate (nelfinavir)

Snippet

Sponsor: AIDS Malignancy Consortium | Conditions: Recurrent Kaposi Sarcoma, Skin Kaposi Sarcoma | Phase 2 | Status: COMPLETED | Results posted: 2024-02-02